Condition: Hereditary Spastic Paraplegia · Hereditary, Spastic Paraplegia, Autosomal Dominant · Sponsor: University Hospital Tuebingen
Study goals 1. Prospective longitudinal data on progression in the natural course of SPG4 in presymptomatic mutation carriers prior to clinical disease onset and in early stages of disease 2. Biomarkers providing objective measures of disease activity
This description comes directly from the study's public registry record.
Ludger Schöls, Prof. · +49 7071 / 29 · ludger.schoels@uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| University Hospital Tübingen, Center for Neurology | Tübingen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03206190